|
An era of continuous transformation for pharmaceutical and medical products companies is forcing business leaders to evolve more quickly. Issues such as consolidation, licensing, tapping the biotech pipeline, and evolving the sales force model will define which companies succeed and which won't.
Read full executive insight 
 Service Offerings - review the services we provide our clients.
Latest Thinking - read our recent articles from the McKinsey Quarterly.
 | | | Seizing China's Pharma Opportunity | | The McKinsey Quarterly, February 2007
China's pharmaceutical market is growing by upward of 20 percent a year, but global drug companies still must capture its full potential.
| | Read more on the McKinsey Quarterly site |
|
| | | Building Japan's Generic-Drug Market | | The McKinsey Quarterly, December 2007
Makers of generic and branded drugs alike stand to gain by developing the country's fledgling market.
| | Read more on the McKinsey Quarterly site |
|
| | | Improving Quality in Pharma Manufacturing | | The McKinsey Quarterly, September 2007
For pharmaceutical and medical-product companies, adopting world-class manufacturing processes can create a competitive advantage by reducing regulatory risk and production costs.
| | Read more on the McKinsey Quarterly site |
|
| | | Using IT to Speed Up Clinical Trials | | The McKinsey Quarterly, July 2007
The first wave of IT improvements solved some problems, but opportunities remain. Now it’s time for a more comprehensive approach.
| | Read more on the McKinsey Quarterly site |
|
|
|
|
|
| | Contact Information | |
| The McKinsey Quarterly | |
| Related Practices | |
| |
|
|
